Skip to main content
Day.News — Local News. Real Community.
247 neighbors reading now

Boyd & Holt Region Day News

Where the prairie meets genuine hospitality.Boyd & Holt Region, NE Edition
health
5 min read

Thousands Died Last Year After Missing Recommended Cancer Screenings, CDC Reports

June 12, 2026

Thousands of people died last year because they were not screened for colon or breast cancer, according to a new Centers for Disease Control and Prevention (CDC) report released Tuesday in the CDC Vital Signs monthly report.

The CDC reported that while many Americans undergo cancer screenings, a significant number still do not receive the recommended tests. This lack of screening increases the risk of late-stage diagnosis and death from these diseases.

The report highlights the importance of regular screening for breast and colorectal cancers. Screening tests can detect cancers early, when treatment is more likely to be successful. Increased screening rates could save lives and improve overall public health.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

0 ratings submitted

How do you feel about this story?

NA

National Desk

Trust 3.249779 articles1,581,888 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

U

Be respectful and thoughtful in your comments.

Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Upcoming Events

Advertisement
Sponsor Message

Related Stories

Weekly Semaglutide Improves Quality of Life for Patients With Diabetes and Kidney Disease

Weekly Semaglutide Improves Quality of Life for Patients With Diabetes and Kidney Disease

Semaglutid improves quality of life for patients with diabetes and kidney disease, study finds

Semaglutid improves quality of life for patients with diabetes and kidney disease, study finds

Semaglutide Study Shows Quality-of-Life Improvements in Diabetic Patients With Kidney Disease

Semaglutide Study Shows Quality-of-Life Improvements in Diabetic Patients With Kidney Disease